Secondary Logo

Most Popular Articles

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review

García, Saínza; Martínez-Cengotitabengoa, Mónica; López-Zurbano, Saioa; More

Journal of Clinical Psychopharmacology. 36(4):355-371, August 2016.

Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis

Pérez-Iglesias, Rocio; Mata, Ignacio; Martínez-García, Obdulia; More

Journal of Clinical Psychopharmacology. 32(6):804-808, December 2012.

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

Knapp, Clifford M.; Ciraulo, Domenic A.; Sarid-Segal, Ofra; More

Journal of Clinical Psychopharmacology. 35(1):34-42, February 2015.

A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares

McCall, William Vaughn; Pillai, Anilkumar; Case, Doug; More

Journal of Clinical Psychopharmacology. 38(6):618-621, December 2018.

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Afshar, Hamid; Roohafza, Hamidreza; Mohammad-Beigi, Hamid; More

Journal of Clinical Psychopharmacology. 32(6):797-803, December 2012.

Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores

Ismail, Zahinoor; Peters-Strickland, Timothy; Miguelez, Maia; More

Journal of Clinical Psychopharmacology. 37(3):347-350, June 2017.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; More

Journal of Clinical Psychopharmacology. 37(5):555-561, October 2017.

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

Mazereeuw, Graham; Herrmann, Nathan; Oh, Paul I.; More

Journal of Clinical Psychopharmacology. 36(5):436-444, October 2016.

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

Göhler, Karin; Sokolowska, Marta; Schoedel, Kerri A.; More

Journal of Clinical Psychopharmacology. 39(1):46-56, January/February 2019.

Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users

Shram, Megan J.; Cohen-Barak, Orit; Chakraborty, Bijan; More

Journal of Clinical Psychopharmacology. 35(4):396-405, August 2015.

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France

Limosin, Frédéric; Belhadi, Drifa; Comet, Denis; More

Journal of Clinical Psychopharmacology. 38(1):19-26, February 2018.

Medication Adherence in Outpatients With Severe Mental Disorders: Relation Between Self-Reports and Serum Level

Jónsdóttir, Halldóra; Opjordsmoen, Stein; Birkenaes, Astrid B.; More

Journal of Clinical Psychopharmacology. 30(2):169-175, April 2010.

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder

Fu, Dong-Jing; Turkoz, Ibrahim; Simonson, R. Bruce; More

Journal of Clinical Psychopharmacology. 36(4):372-376, August 2016.

Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning–Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study

Linkovski, Omer; Wheaton, Michael G.; Zwerling, Jordana; More

Journal of Clinical Psychopharmacology. 39(1):91-93, January/February 2019.

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

Zabala, Arantzazu; Bustillo, Mariana; Querejeta, Imanol; More

Journal of Clinical Psychopharmacology. 37(5):569-577, October 2017.

Driving Performance Under Alcohol in Simulated Representative Driving Tasks: An Alcohol Calibration Study for Impairments Related to Medicinal Drugs

Kenntner-Mabiala, Ramona; Kaussner, Yvonne; Jagiellowicz-Kaufmann, Monika; More

Journal of Clinical Psychopharmacology. 35(2):134-142, April 2015.

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

Richards, Cynthia; Iosifescu, Dan V.; Mago, Rajnish; More

Journal of Clinical Psychopharmacology. 38(4):336-343, August 2018.

Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review

Grall-Bronnec, Marie; Sauvaget, Anne; Perrouin, Fanny; More

Journal of Clinical Psychopharmacology. 36(1):63-70, February 2016.

Tapering Clonazepam in Patients With Panic Disorder After at Least 3 Years of Treatment

Nardi, Antonio E.; Freire, Rafael C.; Valença, Alexandre M.; More

Journal of Clinical Psychopharmacology. 30(3):290-293, June 2010.

Next-Day Residual Sedative Effect After Nighttime Administration of an Over-the-Counter Antihistamine Sleep Aid, Diphenhydramine, Measured by Positron Emission Tomography

Zhang, Dongying; Tashiro, Manabu; Shibuya, Katsuhiko; More

Journal of Clinical Psychopharmacology. 30(6):694-701, December 2010.

Drugs Associated With Restless Legs Syndrome: A Case/Noncase Study in the French Pharmacovigilance Database

Perez-Lloret, Santiago; Rey, María Verónica; Bondon-Guitton, Emmanuelle; More

Journal of Clinical Psychopharmacology. 32(6):824-827, December 2012.

Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study

Cressman, Alex M.; Macdonald, Erin M.; Huang, Anjie; More

Journal of Clinical Psychopharmacology. 35(6):667-671, December 2015.

Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Surman, Craig; Ceranoglu, Atilla; Vaudreuil, Carrie; More

Journal of Clinical Psychopharmacology. 39(1):28-38, January/February 2019.

Effectiveness of Venlafaxine in Selective Serotonin Reuptake Inhibitor–Resistant Obsessive-Compulsive Disorder: Experience From a Specialty Clinic in India

Balachander, Srinivas; Kodancha, Prabhath Gujjadi; Arumugham, Shyam Sundar; More

Journal of Clinical Psychopharmacology. 39(1):82-85, January/February 2019.

The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach

Nardi, Antonio E.; Cosci, Fiammetta; Balon, Richard; More

Journal of Clinical Psychopharmacology. 38(4):283-285, August 2018.

Show: